# Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

> **NCT05127980** · — · RECRUITING · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 80 (estimated)

## Conditions studied

- Epstein-Barr Virus (EBV) Infection

## Interventions

- **OTHER:** Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments)
- **OTHER:** Data collection: blood samples (analysed for EBV serology, auto-antibody-testing/biobanking, RNA expression analyses, procalcitonin)
- **OTHER:** Data collection: Patient reported outcome (Fatigue questionnaires)

## Key facts

- **NCT ID:** NCT05127980
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-15
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05127980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05127980, "Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05127980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*